Cargando…

The effectiveness and value of gene therapy for hemophilia: A Summary from the Institute for Clinical and Economic Review’s California Technology Assessment Forum

Detalles Bibliográficos
Autores principales: Tice, Jeffrey A, Walton, Surrey M, Sarker, Jyotirmoy, Moradi, Ashton, Chu, Janet N, Herce-Hagiwara, Belen, Fahim, Shahariar Mohammed, Agboola, Foluso, Rind, David, Pearson, Steven D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387967/
https://www.ncbi.nlm.nih.gov/pubmed/37121251
http://dx.doi.org/10.18553/jmcp.2023.29.5.576
_version_ 1785082003708706816
author Tice, Jeffrey A
Walton, Surrey M
Sarker, Jyotirmoy
Moradi, Ashton
Chu, Janet N
Herce-Hagiwara, Belen
Fahim, Shahariar Mohammed
Agboola, Foluso
Rind, David
Pearson, Steven D
author_facet Tice, Jeffrey A
Walton, Surrey M
Sarker, Jyotirmoy
Moradi, Ashton
Chu, Janet N
Herce-Hagiwara, Belen
Fahim, Shahariar Mohammed
Agboola, Foluso
Rind, David
Pearson, Steven D
author_sort Tice, Jeffrey A
collection PubMed
description
format Online
Article
Text
id pubmed-10387967
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Academy of Managed Care Pharmacy
record_format MEDLINE/PubMed
spelling pubmed-103879672023-07-31 The effectiveness and value of gene therapy for hemophilia: A Summary from the Institute for Clinical and Economic Review’s California Technology Assessment Forum Tice, Jeffrey A Walton, Surrey M Sarker, Jyotirmoy Moradi, Ashton Chu, Janet N Herce-Hagiwara, Belen Fahim, Shahariar Mohammed Agboola, Foluso Rind, David Pearson, Steven D J Manag Care Spec Pharm Perspectives on Value Academy of Managed Care Pharmacy 2023-05 /pmc/articles/PMC10387967/ /pubmed/37121251 http://dx.doi.org/10.18553/jmcp.2023.29.5.576 Text en Copyright © 2023, Academy of Managed Care Pharmacy. All rights reserved. https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Perspectives on Value
Tice, Jeffrey A
Walton, Surrey M
Sarker, Jyotirmoy
Moradi, Ashton
Chu, Janet N
Herce-Hagiwara, Belen
Fahim, Shahariar Mohammed
Agboola, Foluso
Rind, David
Pearson, Steven D
The effectiveness and value of gene therapy for hemophilia: A Summary from the Institute for Clinical and Economic Review’s California Technology Assessment Forum
title The effectiveness and value of gene therapy for hemophilia: A Summary from the Institute for Clinical and Economic Review’s California Technology Assessment Forum
title_full The effectiveness and value of gene therapy for hemophilia: A Summary from the Institute for Clinical and Economic Review’s California Technology Assessment Forum
title_fullStr The effectiveness and value of gene therapy for hemophilia: A Summary from the Institute for Clinical and Economic Review’s California Technology Assessment Forum
title_full_unstemmed The effectiveness and value of gene therapy for hemophilia: A Summary from the Institute for Clinical and Economic Review’s California Technology Assessment Forum
title_short The effectiveness and value of gene therapy for hemophilia: A Summary from the Institute for Clinical and Economic Review’s California Technology Assessment Forum
title_sort effectiveness and value of gene therapy for hemophilia: a summary from the institute for clinical and economic review’s california technology assessment forum
topic Perspectives on Value
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387967/
https://www.ncbi.nlm.nih.gov/pubmed/37121251
http://dx.doi.org/10.18553/jmcp.2023.29.5.576
work_keys_str_mv AT ticejeffreya theeffectivenessandvalueofgenetherapyforhemophiliaasummaryfromtheinstituteforclinicalandeconomicreviewscaliforniatechnologyassessmentforum
AT waltonsurreym theeffectivenessandvalueofgenetherapyforhemophiliaasummaryfromtheinstituteforclinicalandeconomicreviewscaliforniatechnologyassessmentforum
AT sarkerjyotirmoy theeffectivenessandvalueofgenetherapyforhemophiliaasummaryfromtheinstituteforclinicalandeconomicreviewscaliforniatechnologyassessmentforum
AT moradiashton theeffectivenessandvalueofgenetherapyforhemophiliaasummaryfromtheinstituteforclinicalandeconomicreviewscaliforniatechnologyassessmentforum
AT chujanetn theeffectivenessandvalueofgenetherapyforhemophiliaasummaryfromtheinstituteforclinicalandeconomicreviewscaliforniatechnologyassessmentforum
AT hercehagiwarabelen theeffectivenessandvalueofgenetherapyforhemophiliaasummaryfromtheinstituteforclinicalandeconomicreviewscaliforniatechnologyassessmentforum
AT fahimshahariarmohammed theeffectivenessandvalueofgenetherapyforhemophiliaasummaryfromtheinstituteforclinicalandeconomicreviewscaliforniatechnologyassessmentforum
AT agboolafoluso theeffectivenessandvalueofgenetherapyforhemophiliaasummaryfromtheinstituteforclinicalandeconomicreviewscaliforniatechnologyassessmentforum
AT rinddavid theeffectivenessandvalueofgenetherapyforhemophiliaasummaryfromtheinstituteforclinicalandeconomicreviewscaliforniatechnologyassessmentforum
AT pearsonstevend theeffectivenessandvalueofgenetherapyforhemophiliaasummaryfromtheinstituteforclinicalandeconomicreviewscaliforniatechnologyassessmentforum
AT ticejeffreya effectivenessandvalueofgenetherapyforhemophiliaasummaryfromtheinstituteforclinicalandeconomicreviewscaliforniatechnologyassessmentforum
AT waltonsurreym effectivenessandvalueofgenetherapyforhemophiliaasummaryfromtheinstituteforclinicalandeconomicreviewscaliforniatechnologyassessmentforum
AT sarkerjyotirmoy effectivenessandvalueofgenetherapyforhemophiliaasummaryfromtheinstituteforclinicalandeconomicreviewscaliforniatechnologyassessmentforum
AT moradiashton effectivenessandvalueofgenetherapyforhemophiliaasummaryfromtheinstituteforclinicalandeconomicreviewscaliforniatechnologyassessmentforum
AT chujanetn effectivenessandvalueofgenetherapyforhemophiliaasummaryfromtheinstituteforclinicalandeconomicreviewscaliforniatechnologyassessmentforum
AT hercehagiwarabelen effectivenessandvalueofgenetherapyforhemophiliaasummaryfromtheinstituteforclinicalandeconomicreviewscaliforniatechnologyassessmentforum
AT fahimshahariarmohammed effectivenessandvalueofgenetherapyforhemophiliaasummaryfromtheinstituteforclinicalandeconomicreviewscaliforniatechnologyassessmentforum
AT agboolafoluso effectivenessandvalueofgenetherapyforhemophiliaasummaryfromtheinstituteforclinicalandeconomicreviewscaliforniatechnologyassessmentforum
AT rinddavid effectivenessandvalueofgenetherapyforhemophiliaasummaryfromtheinstituteforclinicalandeconomicreviewscaliforniatechnologyassessmentforum
AT pearsonstevend effectivenessandvalueofgenetherapyforhemophiliaasummaryfromtheinstituteforclinicalandeconomicreviewscaliforniatechnologyassessmentforum